More on SNDX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (9.0 Score)

Upcoming Events

- Earnings (8/4/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Syndax Pharmaceuticals (NQ:SNDX)
Delayed: 22.07 +0.49 (2.27%)
Prev. Close $21.58  
Open$21.00 
52 Wk High$18.03 
52 Wk Low$8.97 
Day High$22.20 
Day Low$21.00 
P/E N/A  
EPS$0.00 
Volume1,390,257 

Friends, Peers and Foes (?): AGIO, APLS, ASND, BBIO, JAZZ (more...)

Mar 4, 2026 04:01 PM Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb 27, 2026 12:03 PM Syndax Pharmaceuticals (SNDX) PT Raised to $45 at Stifel
Feb 26, 2026 04:40 PM Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 19c
Feb 26, 2026 04:33 PM Form S-8 Syndax Pharmaceuticals
Feb 26, 2026 04:08 PM Form 10-K Syndax Pharmaceuticals For: Dec 31
Feb 26, 2026 04:04 PM Form 8-K Syndax Pharmaceuticals For: Feb 26
Feb 26, 2026 04:01 PM Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 23, 2026 07:00 AM Syndax Announces Participation in March Investor Conferences
Feb 19, 2026 07:00 AM Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026
Feb 10, 2026 09:01 AM Form 4 Syndax Pharmaceuticals For: Feb 09 Filed by: Metzger Michael A
View All Articles

Entities mentioned with SNDX

View All Entities